Yatein

Details

Top
Internal ID e8575c09-3e4d-484b-a395-36077c408280
Taxonomy Lignans, neolignans and related compounds > Furanoid lignans > Tetrahydrofuran lignans > 9,9-epoxylignans > Dibenzylbutyrolactone lignans
IUPAC Name (3R,4R)-4-(1,3-benzodioxol-5-ylmethyl)-3-[(3,4,5-trimethoxyphenyl)methyl]oxolan-2-one
SMILES (Canonical) COC1=CC(=CC(=C1OC)OC)CC2C(COC2=O)CC3=CC4=C(C=C3)OCO4
SMILES (Isomeric) COC1=CC(=CC(=C1OC)OC)C[C@@H]2[C@H](COC2=O)CC3=CC4=C(C=C3)OCO4
InChI InChI=1S/C22H24O7/c1-24-19-9-14(10-20(25-2)21(19)26-3)7-16-15(11-27-22(16)23)6-13-4-5-17-18(8-13)29-12-28-17/h4-5,8-10,15-16H,6-7,11-12H2,1-3H3/t15-,16+/m0/s1
InChI Key GMLDZDDTZKXJLU-JKSUJKDBSA-N
Popularity 20 references in papers

Physical and Chemical Properties

Top
Molecular Formula C22H24O7
Molecular Weight 400.40 g/mol
Exact Mass 400.15220310 g/mol
Topological Polar Surface Area (TPSA) 72.40 Ų
XlogP 3.80
Atomic LogP (AlogP) 3.02
H-Bond Acceptor 7
H-Bond Donor 0
Rotatable Bonds 7

Synonyms

Top
40456-50-6
(-)-yatein
Dihydroanhydropodorhizol
(-)-deoxypodorhizone
Deoxypodorhizone
CHEBI:4553
CHEMBL471067
2(3H)-Furanone, 4-(1,3-benzodioxol-5-ylmethyl)dihydro-3-((3,4,5-trimethoxyphenyl)methyl)-, trans-(-)-
(3R,4R)-4-(1,3-benzodioxol-5-ylmethyl)-3-[(3,4,5-trimethoxyphenyl)methyl]oxolan-2-one
(3~{R},4~{R})-4-(1,3-benzodioxol-5-ylmethyl)-3-[(3,4,5-trimethoxyphenyl)methyl]oxolan-2-one
There are more than 10 synonyms. If you wish to see them all click here.

2D Structure

Top
2D Structure of Yatein

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9868 98.68%
Caco-2 + 0.7276 72.76%
Blood Brain Barrier + 0.6750 67.50%
Human oral bioavailability - 0.6714 67.14%
Subcellular localzation Mitochondria 0.7652 76.52%
OATP2B1 inhibitior - 1.0000 100.00%
OATP1B1 inhibitior + 0.9345 93.45%
OATP1B3 inhibitior + 0.9640 96.40%
MATE1 inhibitior - 0.7400 74.00%
OCT2 inhibitior - 0.7500 75.00%
BSEP inhibitior + 0.9379 93.79%
P-glycoprotein inhibitior + 0.8022 80.22%
P-glycoprotein substrate - 0.8381 83.81%
CYP3A4 substrate + 0.5569 55.69%
CYP2C9 substrate + 0.5905 59.05%
CYP2D6 substrate - 0.7552 75.52%
CYP3A4 inhibition + 0.9242 92.42%
CYP2C9 inhibition + 0.8450 84.50%
CYP2C19 inhibition + 0.9606 96.06%
CYP2D6 inhibition - 0.5450 54.50%
CYP1A2 inhibition + 0.5438 54.38%
CYP2C8 inhibition - 0.6329 63.29%
CYP inhibitory promiscuity + 0.9161 91.61%
UGT catelyzed - 0.0000 0.00%
Carcinogenicity (binary) - 0.9400 94.00%
Carcinogenicity (trinary) Non-required 0.4853 48.53%
Eye corrosion - 0.9816 98.16%
Eye irritation - 0.8558 85.58%
Skin irritation - 0.8509 85.09%
Skin corrosion - 0.9751 97.51%
Ames mutagenesis - 0.5800 58.00%
Human Ether-a-go-go-Related Gene inhibition + 0.8023 80.23%
Micronuclear + 0.6200 62.00%
Hepatotoxicity + 0.6000 60.00%
skin sensitisation - 0.5856 58.56%
Respiratory toxicity + 0.6000 60.00%
Reproductive toxicity + 0.6222 62.22%
Mitochondrial toxicity + 0.5750 57.50%
Nephrotoxicity + 0.4762 47.62%
Acute Oral Toxicity (c) III 0.5818 58.18%
Estrogen receptor binding + 0.9003 90.03%
Androgen receptor binding + 0.6610 66.10%
Thyroid receptor binding + 0.6214 62.14%
Glucocorticoid receptor binding + 0.7267 72.67%
Aromatase binding - 0.6540 65.40%
PPAR gamma + 0.6951 69.51%
Honey bee toxicity - 0.7164 71.64%
Biodegradation - 0.8250 82.50%
Crustacea aquatic toxicity - 0.5600 56.00%
Fish aquatic toxicity + 0.9899 98.99%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
CHEMBL340 P08684 Cytochrome P450 3A4 1000 nM
IC50
PMID: 15679319

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL4040 P28482 MAP kinase ERK2 99.20% 83.82%
CHEMBL4303 P08238 Heat shock protein HSP 90-beta 98.34% 96.77%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 97.98% 94.45%
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 95.94% 96.09%
CHEMBL2373 P21730 C5a anaphylatoxin chemotactic receptor 95.73% 92.62%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 95.63% 91.11%
CHEMBL4481 P35228 Nitric oxide synthase, inducible 95.53% 94.80%
CHEMBL2581 P07339 Cathepsin D 95.47% 98.95%
CHEMBL4261 Q16665 Hypoxia-inducible factor 1 alpha 93.65% 85.14%
CHEMBL261 P00915 Carbonic anhydrase I 90.39% 96.76%
CHEMBL1293249 Q13887 Kruppel-like factor 5 90.27% 86.33%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 88.63% 95.56%
CHEMBL1907603 Q05586 Glutamate NMDA receptor; GRIN1/GRIN2B 87.39% 95.89%
CHEMBL2635 P51452 Dual specificity protein phosphatase 3 86.71% 94.00%
CHEMBL3060 Q9Y345 Glycine transporter 2 86.65% 99.17%
CHEMBL4478 Q00975 Voltage-gated N-type calcium channel alpha-1B subunit 86.01% 97.14%
CHEMBL5608 Q16288 NT-3 growth factor receptor 84.04% 95.89%
CHEMBL1075094 Q16236 Nuclear factor erythroid 2-related factor 2 83.88% 96.00%
CHEMBL3137262 O60341 LSD1/CoREST complex 83.05% 97.09%
CHEMBL253 P34972 Cannabinoid CB2 receptor 82.08% 97.25%
CHEMBL5311 P37023 Serine/threonine-protein kinase receptor R3 81.26% 82.67%
CHEMBL1806 P11388 DNA topoisomerase II alpha 80.85% 89.00%
CHEMBL3401 O75469 Pregnane X receptor 80.24% 94.73%

Cross-Links

Top
PubChem 442835
NPASS NPC210354
ChEMBL CHEMBL471067
LOTUS LTS0144117
wikiData Q27106408